Tyler’s Law
Summary
What This Bill Does
Tyler's Law directs HHS to evaluate whether and how hospital emergency departments test overdose patients for fentanyl. Within one year, HHS must study how often emergency departments test for fentanyl in addition to other substances, the costs of fentanyl testing, the potential patient benefits and risks, and effects on patient experience, including privacy of personal health information and the patient-physician relationship. Within six months after completing the study, HHS must issue guidance on whether emergency departments should make fentanyl testing routine for overdose patients, how hospitals can ensure clinicians know which substances are included in routine drug tests, and how fentanyl testing may affect future overdose risk and general health outcomes.
Who Benefits and How
Overdose patients benefit if emergency departments gain clearer evidence on when fentanyl testing improves treatment, counseling, and follow-up care. Emergency physicians benefit from guidance on whether routine drug panels include fentanyl and how testing affects clinical decisions. Hospitals benefit from federal guidance before investing in routine fentanyl testing protocols. Patient privacy officers benefit because the study must address confidentiality and personal health information protections.
Who Bears the Burden and How
The Department of Health and Human Services must complete the study within one year and issue guidance within six months after completion. Hospital emergency departments may need to review testing protocols, clinician training, and patient-privacy workflows after guidance. Clinical laboratory vendors may face demand for fentanyl testing capacity and cost data. Patients could face privacy or relationship concerns if fentanyl testing is implemented without careful safeguards.
Key Provisions
- Requires an HHS study of fentanyl testing frequency, costs, benefits, risks, and patient experience in emergency departments.
- Requires guidance on whether routine fentanyl testing should be used for overdose patients.
- Requires guidance on clinician awareness of substances included in routine drug tests.
- Requires HHS to consider future overdose risk, general health outcomes, privacy, and patient-physician effects.
Evidence Chain:
This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers.
At a Glance
What This Bill Does
Requires HHS to study fentanyl testing in hospital emergency departments for overdose patients and then issue guidance on routine testing, clinician awareness of tested substances, and health effects.
Key Policy Areas
Health Care, Fentanyl, Emergency Medicine
Primary Purpose
Requires HHS to study fentanyl testing in hospital emergency departments for overdose patients and then issue guidance on routine testing, clinician awareness of tested substances, and health effects.
Policy Domains
Resolution provisions
Identified Gains
Contextual inference, no direct clause citation- Overdose patients
- Emergency physicians
- Hospitals
- Patient privacy officers
Contextual inference, no direct clause citation
Identified Costs
Contextual inference, no direct clause citation- Department of Health and Human Services
- Hospital emergency departments
- Clinical laboratory vendors
- Patients with privacy concerns
Contextual inference, no direct clause citation
Sponsors
Legislative Progress
In CommitteeMr. Lieu (for himself, Mr. Latta, Ms. Kamlager-Dove, Mr. Grijalva, …
Referred to the House Committee on Energy and Commerce.
Introduced in House
Bill Structure & Actor Mappings
Who is "The Secretary" in each section?
We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.
Learn more about our methodology